Skip to content
    Real-World Studies

    Recurrent Bloodstream Infection in Hematological Malignancies

    Tang et alFrontiers in Cellular and Infection Microbiology

    In a multicenter real-world study across three academic teaching hospitals evaluating 1,153 patients with hematological malignancies and bloodstream infections (BSIs) between and , recurrent bloodstream infection (RBSI) emerged as a high-mortality complication. Overall, 173 patients (15.0%) developed RBSI following apparent resolution of their initial infection.
    Mortality escalated progressively with each subsequent episode of infection. Baseline mortality was 10.7%, rising significantly to 19.0% after the first recurrence and reaching 30.5% following a second recurrence (P < 0.01), underscoring the compounding prognostic risk of repeated bacteremic events in immunocompromised hosts.
    Time-specific risk stratification identified critical predictors at both the index presentation and subsequent presentations. At the time of initial BSI, a Charlson Comorbidity Index (CCI) >3 was significantly associated with subsequent infection recurrence. During later febrile episodes occurring after initial resolution, patients with RBSI exhibited a higher prevalence of CCI >3, prior antibiotic exposure, acute respiratory failure, and severe thrombocytopenia (platelet count <10 × 10^9/L; all P < 0.05). Recognizing high baseline comorbidity alongside these acute clinical indicators during post-resolution fevers provides a clinical framework to identify patients at elevated risk for recurrent bacteremia and initiate timely, targeted therapeutic interventions.

    Key Takeaways

    • Recurrent bloodstream infection developed in 15.0% (173 of 1,153) of patients with hematological malignancies, with mortality increasing significantly from 10.7% to 19.0% after the first recurrence and to 30.5% following the second recurrence (P < 0.01).
    • At the initial infection, a Charlson Comorbidity Index greater than 3 predicted recurrence, while Charlson Comorbidity Index greater than 3, prior antibiotic exposure, acute respiratory failure, and platelet count below 10 × 10^9/L were significantly enriched during subsequent febrile episodes in patients who developed recurrent infection (all P < 0.05).
    Read the original sourceFrontiers in Cellular and Infection Microbiology